SUMMARY Bradykinin concentrations in peripheral venous blood were measured in seven patients with carcinoid syndrome. The diagnosis was based on typical symptoms and raised urinary excretion of 5-hydroxy-3-indole acetic acid; the carcinoid tumour was verified histologically. Two patients were flushing constantly and the other patients had flushing attacks two to 10 times daily. Several blood samples were taken at weekly intervals from six of seven patients. 
SUMMARY Bradykinin concentrations in peripheral venous blood were measured in seven patients with carcinoid syndrome. The diagnosis was based on typical symptoms and raised urinary excretion of 5-hydroxy-3-indole acetic acid; the carcinoid tumour was verified histologically. Two patients were flushing constantly and the other patients had flushing attacks two to 10 times daily. Several blood samples were taken at weekly intervals from six of seven patients. During 30 sampling procedures the patients were flushing during sampling in 12 instances. Bradykinin was measured by a sensitive solid phase radioimmunoassay technique. Blood bradykinin concentration was normal in all patients. Bradykinin is unlikely to be the vasoactive mediator of flushing. bradvkinin, the recovery has beenl determiinied as 2 .2±+ 12.5% (mean±l SD, n-=2), when corrected for internal stcandcard recovery)' The senisitivity of the assay is 3 pg bradykinin/ml blood, and the between assay coefficient of variation is below 1l6. I n normal subjects, venous blood concentration of bradvkinin is below 5 pg bradykinin/ml whole blood.
Results
The concentration of bradykinin in whole blood was found to be less than 5 pg/ml in all seven patients, which is normal. It is now known that carcinoid tumours may produce other biologically vasoactive substances such as histamine,2' prostaglandins,' substance P,'2 substance K, and eledoisin2' The three latter substances belong to the taichykinins. The relationship between these substances and the clinical manifestations is, however, still not known.
We cainnot conclude from this present study that braidykinin is without any importance in the development of the carcinoid syndrome, but our results indicate that braidykinin is unlikely to be the vasoactive mediator of flushing in these paitients.
